Somalogic stock.

SomaLogic, Inc. Warrant (SLGCW) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.SomaLogic now expects revenue for the full year 2022 of $80.0 to $90.0 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Monday, August 15, 2022 to discuss its second quarter 2022 financial results. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and …SomaLogic Inc Class A SLGC Morningstar Rating Stock XNAS Rating as of Nov 21, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating...SomaLogic is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado. It became listed on Nasdaq in September 2021 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. [2]

Nov 29, 2023 · After this action, Taich Adam now owns 238,643 shares of SomaLogic Inc, valued at $50,286 using the latest closing price. Gutierrez Ruben, the General Counsel of SomaLogic Inc, sale 9,211 shares at $2.33 during a trade that took place back on Sep 15, which means that Gutierrez Ruben is holding 110,534 shares at $21,460 based on the most recent ... SLGC Sales Forecast. Next quarter’s sales forecast for SLGC is $21.05M with a range of $20.60M to $21.60M. The previous quarter’s sales results were $22.05M. SLGC beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 45.92% of the time in the same period.

Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...

Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...SomaLogic ( CMII) ( CMIIU) is currently the leader in next generation proteomics with a suite of products already on the market giving SomaLogic first mover advantage in next gen platforms. The ...Ark Investment Management has been accumulating the stock recently and owns 3.1% of SomaLogic stock. The current market cap of the company is $2.03B and the enterprise value is $1.8B. Over a long ...The average Somalogic stock price prediction forecasts a potential downside of 2.04% from the current SLGC share price of $2.45. What is SLGC's forecast return on assets (ROA) for 2023-2025? (NASDAQ: SLGC) forecast ROA is -9.99%, which is lower than the forecast US Health Information Services industry average of 8.41%.

Somalogic story: Study finds proteomic risk scores for cardiovascular disease from SomaSignal Cardio DM tests could support physicians in managing patient outcomes and other headlines for Somalogic Stock

SomaLogic, Inc. (SLGCW) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 0.1500 0.0000 (0.00%) At close: 10:20AM EST 1d 5d 1m 6m YTD 1y 5y Max Full screen Trade prices are not sourced...

Standard BioTools, SomaLogic to Merge. Oct 04, 2023 | staff reporter. Save for later. NEW YORK – Standard BioTools, formerly known as Fluidigm, and SomaLogic said on Wednesday that they will merge in an all-stock deal to create a company worth over $1 billion.Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools. GlobeNewswire 61d. Start Trading >> Plus500. 81% of retail CFD accounts lose money.SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools …Nov 18, 2023 · SomaLogic, Inc. (NASDAQ:SLGCW – Get Free Report)’s stock price rose 6.3% on Wednesday . The company traded as high as $0.17 and last traded at $0.17. Approximately 72,147 shares were traded during trading, an increase of 1,225% from the average daily volume of 5,446 shares. The stock had previously closed at $0.16. SomaLogic Stock Performance […] Nov 27, 2023 · View SomaLogic, Inc SLGC investment & stock information. Get the latest SomaLogic, Inc SLGC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Explore new charts. Discover historical prices for SLGC stock on Yahoo Finance. View daily, weekly or monthly format back to when SomaLogic, Inc. stock was issued.

BOULDER, Colo. and SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire ...Nov 8, 2023 · SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ... Nov 18, 2023 · SomaLogic, Inc. (NASDAQ:SLGCW – Get Free Report)’s stock price rose 6.3% on Wednesday . The company traded as high as $0.17 and last traded at $0.17. Approximately 72,147 shares were traded during trading, an increase of 1,225% from the average daily volume of 5,446 shares. The stock had previously closed at $0.16. SomaLogic Stock Performance […] Revenue for the 3 months ended September 30, 2023, was $22 million as compared to $41.7 million in the third quarter of 2022, a 47% year-over-year decline on a GAAP basis. Excluding $22.3 million ...Oct 4, 2023 · SomaLogic Inc.'s (SLGC) stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with ... Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and ...UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Dec 4, 2023 · Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools. GlobeNewswire 61d. Start Trading >> Plus500. 81% of retail CFD accounts lose money.

SomaLogic (Nasdaq: SLGC) is fostering the discovery of effective and safer treatments for patients in need while empowering more accurate diagnosis, prevention, and treatment of disease through the next generation of proteomics. Powered by an industry-leading technology platform comprised of both assay services and diagnostics in …View Your Watchlist. Stock analysis for SomaLogic Inc (SLGC:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and …Oct 4, 2023 · Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ... SomaLogic projects revenue for the full year 2023 to range from $80 million to $84 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Tuesday, March 28, 2023 to discuss its fourth quarter 2022 financial results. Those interested in listening to the conference call should register online here ...Oct 4, 2023 · SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools shareholders will own 43% of the ... Appointed Eliot Lurier, CPA, to Interim Chief Financial Officer. Second Quarter 2023 Financial Results. Revenue for the three months ended June 30, 2023 was $20.5 million, a 45% increase from $14.1 million in the corresponding period of 2022. Excluding Q2 2022 royalty revenue from NEB, revenue grew 55%. Gross margin for the three months ended ...Nov 8, 2023 · SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ... Standard BioTools, SomaLogic to Merge. Oct 04, 2023 | staff reporter. Save for later. NEW YORK – Standard BioTools, formerly known as Fluidigm, and SomaLogic said on Wednesday that they will merge in an all-stock deal to create a company worth over $1 billion.

BOULDER — SomaLogic Inc. (Nasdaq: SLGC) and California-based Standard BioTools Inc. (Nasdaq: LAB) have agreed to an all-stock merger deal that is expected to result in a combined company valued at more than $1 billion. Existing executives with both companies will lead the combined organization, which will carry the Standard BioTools name.

SomaLogic, Inc. Class A Common Stock (SLGC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

The all-time high SomaLogic stock closing price was 14.28 on November 05, 2021. The SomaLogic 52-week high stock price is 3.79, which is 37.8% above the current share price. The SomaLogic 52-week low stock price is 1.73, which is 37.1% below the current share price. The average SomaLogic stock price for the last 52 weeks is 2.55.21 ago 2023 ... Shane Bowen. (Id. ¶ 35.) As required by the parties' agreements, SomaLogic paid Dr. Gopinath his portion of the Upfront Stock Consideration upon ...THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between SomaLogic, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the SomaLogic, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time …SomaLogic, Inc. (SLGCW) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 0.1500 0.0000 (0.00%) At close: 10:20AM EST 1d 5d 1m 6m YTD 1y 5y Max Full screen Trade prices are not sourced...Find the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing.Standard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the ...Nov 28, 2022 · SomaLogic, Inc.(NASDAQ:SLGC): Well-known investor Cathie Wood has recently bought shares of healthcare company SomaLogic (SLGC) for less than $5. However, given the stock’s more than 75% fall this year, would it be a wise buy now? Read on to find out… SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in ...Oct 4, 2023 · SomaLogic Inc.'s (SLGC) stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with ... Find the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing.After this action, Taich Adam now owns 238,643 shares of SomaLogic Inc, valued at $50,286 using the latest closing price. Gutierrez Ruben, the General Counsel of SomaLogic Inc, sale 9,211 shares at $2.33 during a trade that took place back on Sep 15, which means that Gutierrez Ruben is holding 110,534 shares at $21,460 based on the most recent ...Income Statement for Somalogic Inc (SLGC) with Annual and Quarterly reports. Income Statement for Somalogic Inc (SLGC) ... Stock Market Overview Market Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Standard BioTools Inc. and SomaLogic, Inc. is fair to Standard BioTools shareholders. Under the terms of the...Jefferies Downgrades SomaLogic to Hold From Buy, Adjusts Price Target to $2.30 From $3.50. Oct. 05. MT. Canaccord Genuity Downgrades SomaLogic to Hold From Buy, Cuts Price Target to $2.50 From $5. Sep. 25. MT. Canaccord Genuity Adjusts Price Target on SomaLogic to $5 From $6, Maintains Buy Rating. Mar. 29.SomaLogic, Inc. Class A Common Stock (SLGC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.SomaLogic stock tumbles aftermarket as revenue outlook slashed on macro headwinds SA News Mon, Aug. 15, 2022. SomaLogic GAAP EPS of -$0.13 beats by $0.05, revenue of $14.1M misses by $10.72MInstagram:https://instagram. 6 month treasury ratesdelta dental veteransbuy amazon sharesbooks business development SLGC | Complete SomaLogic Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. best china etfsfrc.stock SomaLogic saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 7,810,000 shares, a drop of 1.1% from the previous total of 7,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. american association of individual investors reviews Find the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing.SomaLogic now expects revenue for the full year 2022 of $80.0 to $90.0 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Monday, August 15, 2022 to discuss its second quarter 2022 financial results. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and …